Solution reagent kit MD07331

clinicalRT-qPCRinfluenza A

Influenza A and B viruses are the two primary types responsible for seasonal flu outbreaks in humans, with Influenza A being more genetically diverse and capable of causing pandemics, while Influenza B tends to cause milder illness. Both influenza viruses are highly contagious respiratory diseases transmitted via contact, respiratory droplets (coughing and sneezing) and contaminated surfaces. Influenza A virus & Influenza B virus RT-qPCR Kit is designed for the in vitro detection of Influenza A and Influenza B viruses. The kit is built to have the broadest possible detection profile whilst remaining specific to Influenza A and Influenza B viruses. Thus, this kit has been designed for the specific (inclusivity) and exclusive (exclusivity) in vitro detection of these viruses. The primers and probe sequences have very high (>95%) homology with a broad range of Influenza A and Influenza B viruses genomes based on a comprehensive bioinformatic analysis with all reference data within the NCBI databases at the time of design. Due to the inherent instability of RNA viral genomes, it is not possible to guarantee the detection of all clinical isolates. This kit was meticulously designed and validated to meet the rigorous criteria of a quantitative assay. However, it is important to note that the provided Positive Control is not intended for quantification purposes. We recommend checking NZYtech website for the availability of a suitable Quantitative Standard for an accurate quantification. In alternative, commercially genomic RNA standards can also be used.